707 related articles for article (PubMed ID: 25617860)
1. A concise review of non-alcoholic fatty liver disease.
Than NN; Newsome PN
Atherosclerosis; 2015 Mar; 239(1):192-202. PubMed ID: 25617860
[TBL] [Abstract][Full Text] [Related]
2. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
Clemente MG; Mandato C; Poeta M; Vajro P
World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
[TBL] [Abstract][Full Text] [Related]
3. The intersection of nonalcoholic fatty liver disease and obesity.
Woo Baidal JA; Lavine JE
Sci Transl Med; 2016 Jan; 8(323):323rv1. PubMed ID: 26819197
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
Schuppan D; Schattenberg JM
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
[TBL] [Abstract][Full Text] [Related]
5. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Faghihzadeh F; Adibi P; Hekmatdoost A
Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
Lim S; Oh TJ; Koh KK
Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
[TBL] [Abstract][Full Text] [Related]
7. Management of fatty liver disease with the metabolic syndrome.
Machado MV; Cortez-Pinto H
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):487-500. PubMed ID: 24665862
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
Pallayova M; Taheri S
Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
Petta S; Muratore C; Craxì A
Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
[TBL] [Abstract][Full Text] [Related]
10. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
Byrne CD
Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease].
Kim HS; Cho YK
Korean J Gastroenterol; 2017 Jun; 69(6):333-340. PubMed ID: 28637101
[TBL] [Abstract][Full Text] [Related]
12. NAFLD: a multisystem disease.
Byrne CD; Targher G
J Hepatol; 2015 Apr; 62(1 Suppl):S47-64. PubMed ID: 25920090
[TBL] [Abstract][Full Text] [Related]
13. [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease].
Drapkina OM; Deeva TA; Volkova NP; Ivashkin VT
Ter Arkh; 2014; 86(10):116-23. PubMed ID: 25509904
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease.
Leclercq I
Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266
[TBL] [Abstract][Full Text] [Related]
15. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
Santos RD; Valenti L; Romeo S
Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
17. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.
Cimini FA; Barchetta I; Carotti S; Bertoccini L; Baroni MG; Vespasiani-Gentilucci U; Cavallo MG; Morini S
World J Gastroenterol; 2017 May; 23(19):3407-3417. PubMed ID: 28596677
[TBL] [Abstract][Full Text] [Related]
18. Paediatric non-alcoholic fatty liver disease: an overview.
AlKhater SA
Obes Rev; 2015 May; 16(5):393-405. PubMed ID: 25753407
[TBL] [Abstract][Full Text] [Related]
19. Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation.
Lozano-Bartolomé J; Llauradó G; Rodriguez MM; Fernandez-Real JM; Garcia-Fontgivell JF; Puig J; Maymó-Masip E; Vendrell J; Chacón MR
Int J Obes (Lond); 2016 Sep; 40(9):1337-45. PubMed ID: 27121253
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?
Ahmed MH; Ali A
Scand J Gastroenterol; 2014 May; 49(5):521-7. PubMed ID: 24646400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
